Patients on the new insurance exchanges are more likely to have received brand name drugs for their chronic conditions, according to a report from The Washington Post.
Numbers from Express Scripts on pharmacy benefits indicated exchange enrollees in January and February received specialty medications more than 1 percent of the time for conditions such as cancer, hepatitis C and HIV. That number is somewhat less than 1 percent for commercial health plans. These prescriptions account for less than 1 percent of prescriptions and nearly one-quarter of spending on pharmaceuticals, according to the report.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
While the trend may be worrying, it is not yet a major cause for concern, according to the report, as health plans have only analyzed very early data on their new enrollees.
More Articles on Infection Control & Clinical Quality:
6 Findings on CAUTI Burden and Outcomes
Infant Age Affects Post-Op Infection Risk Reduction Procedures
S.C. Hospitals Aim for Checklist Use in Every OR, Expect $28M in Savings